CLINDAMYCIN HYDROCHLORIDE

CLINDAMYCIN HYDROCHLORIDE was reported 3524 times

CLINDAMYCIN HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 EXERTIONAL HEADACHE 3 0.0469
1 TENDINOUS CONTRACTURE 4 0.0351
2 AEROMONAS INFECTION 6 0.0317
3 HYPER IGE SYNDROME 3 0.0263
4 IODINE ALLERGY 7 0.0210
5 CERVICAL CYST 4 0.0169
6 BLADDER TRANSITIONAL CELL CARCINOMA 21 0.0147
7 DAIRY INTOLERANCE 4 0.0142
8 LOSS OF EMPLOYMENT 33 0.0109
9 ENTEROCOLITIS BACTERIAL 3 0.0109
10 TRACHEITIS 8 0.0105
11 NECROTISING OESOPHAGITIS 5 0.0100
12 VASCULAR PURPURA 13 0.0093
13 CELLULITE 3 0.0092
14 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME ASSOCIATED TUBERCULOSIS 3 0.0090
15 PERINEAL ABSCESS 4 0.0089
16 OESOPHAGEAL IRRITATION 5 0.0086
17 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 9 0.0085
18 FOREIGN BODY ASPIRATION 6 0.0083
19 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 55 0.0071
20 PSEUDOMEMBRANOUS COLITIS 14 0.0063
21 ADRENOCORTICOTROPIC HORMONE DEFICIENCY 5 0.0057
22 ALLERGY TO ANIMAL 6 0.0056
23 PARASOMNIA 4 0.0056
24 AXILLARY PAIN 8 0.0054
25 TONGUE COATED 9 0.0052
26 SYMMETRICAL DRUG-RELATED INTERTRIGINOUS AND FLEXURAL EXANTHEMA 4 0.0049
27 HYPERTHERMIA MALIGNANT 7 0.0047
28 ACARODERMATITIS 5 0.0046
29 INFUSION SITE DISCHARGE 8 0.0046
30 JARISCH-HERXHEIMER REACTION 3 0.0042
31 FOREIGN BODY TRAUMA 3 0.0041
32 TOXIC SKIN ERUPTION 41 0.0041
33 HYPERPARATHYROIDISM SECONDARY 10 0.0040
34 POSTOPERATIVE WOUND COMPLICATION 5 0.0039
35 RASH MACULO-PAPULAR 87 0.0039
36 CLOSTRIDIAL INFECTION 13 0.0038
37 HEPATIC CYTOLYSIS 48 0.0038
38 CHRONIC SINUSITIS 14 0.0037
39 ENDOMETRIAL HYPERPLASIA 3 0.0037
40 NOSOCOMIAL INFECTION 8 0.0036
41 CLOSTRIDIUM TEST POSITIVE 8 0.0036
42 CIRCADIAN RHYTHM SLEEP DISORDER 3 0.0036
43 HIDRADENITIS 33 0.0036
44 RASH MORBILLIFORM 10 0.0036
45 CUTANEOUS VASCULITIS 13 0.0036
46 CHRONIC SPONTANEOUS URTICARIA 4 0.0034
47 INFUSION SITE INFECTION 8 0.0034
48 NECROTISING FASCIITIS 12 0.0034
49 AKINESIA 7 0.0034
50 MIXED LIVER INJURY 10 0.0033
51 HYPERKINESIA 7 0.0033
52 ESSENTIAL HYPERTENSION 6 0.0033
53 TOOTH EROSION 4 0.0033
54 NEPHROGENIC ANAEMIA 15 0.0032
55 POST-ACUTE COVID-19 SYNDROME 4 0.0032
56 CEREBRAL TOXOPLASMOSIS 3 0.0032
57 FOREIGN BODY IN THROAT 10 0.0032
58 EOSINOPHILIC PNEUMONIA 10 0.0032
59 INFUSION SITE NODULE 3 0.0031
60 SUSPECTED OFF LABEL USE 14 0.0031
61 CONVERSION DISORDER 6 0.0031
62 BONE MARROW DEPRESSION 3 0.0031
63 CYSTITIS NONINFECTIVE 4 0.0030
64 SINUS OPERATION 7 0.0029
65 SIALOADENITIS 4 0.0029
66 HEPATIC STEATOSIS 54 0.0029
67 DERMATITIS EXFOLIATIVE GENERALISED 10 0.0029
68 CATAPLEXY 4 0.0028
69 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 72 0.0028
70 INFUSION SITE MASS 3 0.0028
71 PULMONARY SEPSIS 4 0.0027
72 CATHETER SITE DISCHARGE 3 0.0027
73 WHITE BLOOD CELLS URINE POSITIVE 5 0.0027
74 PARANASAL SINUS DISCOMFORT 10 0.0026
75 SINUS PAIN 6 0.0026
76 BICYTOPENIA 5 0.0025
77 GROIN ABSCESS 3 0.0025
78 CLOSTRIDIUM DIFFICILE COLITIS 27 0.0025
79 INFUSION SITE PRURITUS 8 0.0025
80 CLOSTRIDIUM COLITIS 3 0.0025
81 INFUSION SITE WARMTH 3 0.0024
82 LARGE INTESTINE INFECTION 3 0.0024
83 PRODUCT ADMINISTRATION INTERRUPTED 19 0.0024
84 DEVICE INFUSION ISSUE 6 0.0024
85 IMMUNE THROMBOCYTOPENIA 11 0.0024
86 OESOPHAGEAL PAIN 9 0.0023
87 HEPATITIS CHOLESTATIC 13 0.0022
88 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 5 0.0021
89 LYME DISEASE 7 0.0021
90 SKIN WARM 12 0.0021
91 GENERALISED ANXIETY DISORDER 3 0.0020
92 ANKLE OPERATION 3 0.0020
93 PNEUMONIA STAPHYLOCOCCAL 4 0.0020
94 TOOTH ABSCESS 20 0.0020
95 OSTEOLYSIS 4 0.0020
96 INFUSION SITE ERYTHEMA 16 0.0019
97 ANGIONEUROTIC OEDEMA 5 0.0019
98 CYSTITIS INTERSTITIAL 3 0.0019
99 INFUSION SITE BRUISING 4 0.0019
100 EXPOSED BONE IN JAW 4 0.0018
101 EOSINOPHILIA 32 0.0018
102 CHOLESTATIC LIVER INJURY 4 0.0018
103 WOUND SECRETION 7 0.0018
104 TOXIC EPIDERMAL NECROLYSIS 27 0.0018
105 WOUND DEHISCENCE 6 0.0018
106 CHOLESTASIS 34 0.0018
107 FOOD AVERSION 3 0.0018
108 PRE-EXISTING CONDITION IMPROVED 11 0.0018
109 KOUNIS SYNDROME 4 0.0018
110 ACUTE SINUSITIS 3 0.0017
111 BURNS SECOND DEGREE 3 0.0017
112 SPINAL OSTEOARTHRITIS 15 0.0017
113 PURPURA 15 0.0017
114 REBOUND ACID HYPERSECRETION 5 0.0017
115 END STAGE RENAL DISEASE 30 0.0016
116 DERMAL CYST 4 0.0016
117 SEASONAL ALLERGY 23 0.0016
118 RETINAL TEAR 4 0.0016
119 OSTEOMYELITIS 29 0.0016
120 TUBULOINTERSTITIAL NEPHRITIS 30 0.0016
121 SYSTEMIC CANDIDA 4 0.0016
122 GINGIVAL RECESSION 3 0.0016
123 OESOPHAGEAL ULCER 6 0.0016
124 AORTIC ARTERIOSCLEROSIS 4 0.0016
125 CONTRAINDICATED PRODUCT ADMINISTERED 47 0.0016
126 ABDOMINAL WALL HAEMATOMA 3 0.0015
127 ORAL INFECTION 6 0.0015
128 INFUSION SITE HAEMORRHAGE 5 0.0015
129 TOOTH INFECTION 20 0.0015
130 EMPYEMA 3 0.0015
131 ANIMAL BITE 4 0.0015
132 PSYCHIATRIC SYMPTOM 11 0.0015
133 ANAESTHETIC COMPLICATION 4 0.0015
134 DECUBITUS ULCER 12 0.0015
135 INFUSION SITE SWELLING 9 0.0014
136 CELLULITIS 72 0.0014
137 INCORRECT DRUG ADMINISTRATION RATE 6 0.0014
138 ABDOMINAL TENDERNESS 7 0.0014
139 PURULENT DISCHARGE 6 0.0014
140 DERMATITIS CONTACT 16 0.0014
141 SKIN WEEPING 5 0.0014
142 INFUSION SITE PAIN 18 0.0014
143 BONE LESION 5 0.0014
144 HENOCH-SCHONLEIN PURPURA 3 0.0014
145 ONYCHOMYCOSIS 6 0.0014
146 ENDOCARDITIS 7 0.0014
147 PLEURISY 8 0.0013
148 INFECTIOUS MONONUCLEOSIS 3 0.0013
149 IDIOPATHIC INTRACRANIAL HYPERTENSION 3 0.0013
150 POSTOPERATIVE WOUND INFECTION 9 0.0013
151 BLOOD LOSS ANAEMIA 3 0.0013
152 SNORING 5 0.0013
153 VASCULAR DEVICE INFECTION 6 0.0013
154 LICHENOID KERATOSIS 3 0.0013
155 GASTRIC INFECTION 5 0.0013
156 CLOSTRIDIUM DIFFICILE INFECTION 28 0.0013
157 OESOPHAGITIS 14 0.0013
158 VULVOVAGINAL MYCOTIC INFECTION 5 0.0013
159 STEVENS-JOHNSON SYNDROME 28 0.0013
160 LOOSE TOOTH 4 0.0012
161 ENURESIS 5 0.0012
162 CHRONIC KIDNEY DISEASE 94 0.0012
163 VULVOVAGINAL DRYNESS 4 0.0012
164 PERIPHERAL VENOUS DISEASE 5 0.0012
165 ARTHRITIS BACTERIAL 5 0.0012
166 BLOOD IMMUNOGLOBULIN G DECREASED 3 0.0012
167 ERYSIPELAS 6 0.0012
168 AGRANULOCYTOSIS 22 0.0012
169 ENDODONTIC PROCEDURE 3 0.0012
170 DENTAL CARIES 13 0.0012
171 ABSCESS LIMB 5 0.0012
172 CONCUSSION 9 0.0012
173 THERAPEUTIC PRODUCT EFFECT DECREASED 52 0.0012
174 ACTINIC KERATOSIS 3 0.0012
175 HYPERSENSITIVITY VASCULITIS 3 0.0011
176 MONOCYTE COUNT INCREASED 4 0.0011
177 ESCHERICHIA INFECTION 9 0.0011
178 HYPERLIPIDAEMIA 13 0.0011
179 ROSACEA 5 0.0011
180 DIARRHOEA HAEMORRHAGIC 10 0.0011
181 ARTERIOSCLEROSIS CORONARY ARTERY 7 0.0011
182 LIP PAIN 3 0.0010
183 LOCALISED INFECTION 25 0.0010
184 STAPHYLOCOCCAL INFECTION 34 0.0010
185 EPIGASTRIC DISCOMFORT 4 0.0010
186 RENAL TUBULAR NECROSIS 10 0.0010
187 BACTERIAL INFECTION 19 0.0010
188 HYPERVOLAEMIA 5 0.0010
189 ODYNOPHAGIA 6 0.0010
190 OESOPHAGEAL CANDIDIASIS 4 0.0010
191 OBSTRUCTION 4 0.0010
192 SKIN PAPILLOMA 4 0.0010
193 CANDIDIASIS 4 0.0010
194 FUNGAL SKIN INFECTION 4 0.0010
195 EMERGENCY CARE 3 0.0010
196 POST PROCEDURAL INFECTION 8 0.0010
197 DIABETIC FOOT 3 0.0010
198 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 4 0.0010
199 PHLEBITIS 5 0.0010
200 GASTRIC DISORDER 33 0.0010
201 APLASTIC ANAEMIA 5 0.0010
202 LIVER DISORDER 42 0.0009
203 ARTHROPOD BITE 7 0.0009
204 TOOTH DISORDER 21 0.0009
205 ANAL ABSCESS 5 0.0009
206 STAPHYLOCOCCAL BACTERAEMIA 4 0.0009
207 SKIN LACERATION 10 0.0009
208 HAEMODYNAMIC INSTABILITY 7 0.0009
209 HEPATOCELLULAR INJURY 13 0.0009
210 BREAST ENLARGEMENT 3 0.0009
211 TONGUE DISCOLOURATION 4 0.0009
212 BOWEL MOVEMENT IRREGULARITY 7 0.0009
213 DEAFNESS NEUROSENSORY 3 0.0009
214 ATRIOVENTRICULAR BLOCK 7 0.0009
215 APPETITE DISORDER 6 0.0009
216 PHYSICAL DISABILITY 4 0.0009
217 IMPAIRED QUALITY OF LIFE 13 0.0009
218 CYTOLYTIC HEPATITIS 3 0.0009
219 DRUG ERUPTION 16 0.0009
220 RHINITIS ALLERGIC 4 0.0009
221 MULTIPLE ALLERGIES 7 0.0009
222 GASTROINTESTINAL INFECTION 8 0.0009
223 IRON DEFICIENCY 4 0.0009
224 CANDIDA INFECTION 15 0.0009
225 SINUS CONGESTION 12 0.0009
226 TOOTH EXTRACTION 11 0.0009
227 TOOTHACHE 16 0.0009
228 BLOOD THYROID STIMULATING HORMONE DECREASED 4 0.0009
229 WEIGHT FLUCTUATION 9 0.0009
230 SHOCK HAEMORRHAGIC 7 0.0009
231 ERYTHEMA MULTIFORME 8 0.0009
232 HANGOVER 3 0.0009
233 DEPRESSIVE SYMPTOM 3 0.0009
234 INSURANCE ISSUE 13 0.0008
235 BONE EROSION 3 0.0008
236 PROTHROMBIN TIME PROLONGED 5 0.0008
237 ORAL CANDIDIASIS 11 0.0008
238 SENSATION OF FOREIGN BODY 7 0.0008
239 VULVOVAGINAL PAIN 4 0.0008
240 RASH PUSTULAR 6 0.0008
241 AUTOIMMUNE DISORDER 8 0.0008
242 ORAL DISORDER 6 0.0008
243 MUSCULOSKELETAL DISCOMFORT 14 0.0008
244 LARYNGEAL OEDEMA 5 0.0008
245 STAPHYLOCOCCAL SEPSIS 4 0.0008
246 SINUSITIS 83 0.0008
247 RENAL INJURY 24 0.0008
248 SINUS DISORDER 16 0.0008
249 SKIN SWELLING 7 0.0008
250 SEPTIC SHOCK 35 0.0008
251 SECRETION DISCHARGE 10 0.0008
252 HEPATIC NECROSIS 3 0.0008
253 PEMPHIGOID 6 0.0008
254 CONJUNCTIVAL HAEMORRHAGE 3 0.0008
255 PETIT MAL EPILEPSY 4 0.0008
256 INITIAL INSOMNIA 8 0.0008
257 PROCTALGIA 5 0.0008
258 ACUTE KIDNEY INJURY 118 0.0008
259 FAECES HARD 3 0.0008
260 GASTROINTESTINAL INFLAMMATION 6 0.0008
261 AFFECTIVE DISORDER 6 0.0008
262 LYMPHADENOPATHY 27 0.0008
263 PRODUCT USE COMPLAINT 12 0.0008
264 NASAL DISCOMFORT 6 0.0008
265 INTERVERTEBRAL DISC DEGENERATION 7 0.0008
266 GINGIVAL PAIN 6 0.0008
267 CARDIAC FAILURE ACUTE 5 0.0007
268 FUNGAL INFECTION 25 0.0007
269 FOOD POISONING 4 0.0007
270 COMPRESSION FRACTURE 4 0.0007
271 POST-TRAUMATIC STRESS DISORDER 5 0.0007
272 SENSORY LOSS 6 0.0007
273 BODY TEMPERATURE INCREASED 15 0.0007
274 HICCUPS 6 0.0007
275 JAW DISORDER 4 0.0007
276 ANAPHYLACTOID REACTION 3 0.0007
277 TENDON RUPTURE 9 0.0007
278 UPPER-AIRWAY COUGH SYNDROME 6 0.0007
279 HYPERKERATOSIS 4 0.0007
280 PSYCHOMOTOR HYPERACTIVITY 12 0.0007
281 HYPERPYREXIA 3 0.0007
282 MULTIPLE ORGAN DYSFUNCTION SYNDROME 20 0.0007
283 EATING DISORDER 15 0.0007
284 PERONEAL NERVE PALSY 4 0.0007
285 INTERVERTEBRAL DISC DISORDER 3 0.0007
286 PSEUDOMONAS INFECTION 6 0.0007
287 RENAL FAILURE 92 0.0007
288 DERMATITIS BULLOUS 5 0.0007
289 ABSCESS 11 0.0007
290 HYPOKINESIA 10 0.0007
291 CARDIAC FAILURE CONGESTIVE 55 0.0007
292 SLEEP APNOEA SYNDROME 13 0.0007
293 RIB FRACTURE 14 0.0007
294 BLOOD PRESSURE DIASTOLIC DECREASED 5 0.0007
295 SKIN HAEMORRHAGE 10 0.0007
296 PETECHIAE 7 0.0007
297 WRIST FRACTURE 8 0.0007
298 ORAL HERPES 13 0.0007
299 LIMB INJURY 18 0.0007
300 DRUG RESISTANCE 17 0.0007
301 ECONOMIC PROBLEM 10 0.0007
302 COLITIS 25 0.0007
303 BLOOD PRESSURE DIASTOLIC INCREASED 3 0.0006
304 UPPER RESPIRATORY TRACT INFECTION 30 0.0006
305 FOOD ALLERGY 5 0.0006
306 PHARYNGITIS STREPTOCOCCAL 7 0.0006
307 TENDONITIS 10 0.0006
308 CYST 8 0.0006
309 OLIGURIA 4 0.0006
310 HYPOALBUMINAEMIA 5 0.0006
311 NEPHROPATHY 6 0.0006
312 SCAR 11 0.0006
313 DRUG INTOLERANCE 62 0.0006
314 TASTE DISORDER 13 0.0006
315 EAR INFECTION 17 0.0006
316 BRAIN FOG 10 0.0006
317 CARDIAC FAILURE 51 0.0006
318 TOOTH FRACTURE 7 0.0006
319 SPINAL DISORDER 6 0.0006
320 FOOT DEFORMITY 7 0.0006
321 ILLNESS 65 0.0006
322 NERVE INJURY 7 0.0006
323 TRICUSPID VALVE INCOMPETENCE 5 0.0006
324 RASH MACULAR 22 0.0006
325 ENDOMETRIOSIS 3 0.0006
326 RECALLED PRODUCT ADMINISTERED 6 0.0006
327 ENTERITIS 4 0.0006
328 SKIN INFECTION 7 0.0006
329 ROTATOR CUFF SYNDROME 8 0.0006
330 ATELECTASIS 6 0.0006
331 ENTEROCOCCAL INFECTION 3 0.0006
332 DERMATITIS 13 0.0006
333 DIZZINESS POSTURAL 6 0.0006
334 LIVER INJURY 15 0.0006
335 SOMNAMBULISM 4 0.0006
336 ANHEDONIA 16 0.0006
337 BREATH SOUNDS ABNORMAL 3 0.0006
338 GASTRITIS 16 0.0006
339 RASH 265 0.0006
340 WALKING AID USER 4 0.0006
341 FOOT OPERATION 3 0.0006
342 IMMUNODEFICIENCY 9 0.0006
343 DERMATITIS EXFOLIATIVE 3 0.0006
344 GASTROOESOPHAGEAL REFLUX DISEASE 48 0.0006
345 BREAST MASS 4 0.0006
346 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 3 0.0006
347 WRONG PRODUCT ADMINISTERED 4 0.0006
348 DYSLIPIDAEMIA 3 0.0006
349 CIRCULATORY COLLAPSE 10 0.0006
350 RASH ERYTHEMATOUS 28 0.0006
351 VITAMIN D DECREASED 5 0.0006
352 THYROID DISORDER 9 0.0006
353 CACHEXIA 3 0.0006
354 JOINT EFFUSION 4 0.0006
355 EYE DISCHARGE 6 0.0006
356 LARGE INTESTINE PERFORATION 4 0.0006
357 RASH PRURITIC 31 0.0006
358 BLOOD LACTIC ACID INCREASED 3 0.0006
359 CARDIOMEGALY 7 0.0006
360 ABDOMINAL DISCOMFORT 95 0.0006
361 EAR PAIN 11 0.0006
362 ULCER 9 0.0006
363 HAND FRACTURE 4 0.0006
364 ANORECTAL DISCOMFORT 3 0.0006
365 HAEMORRHOIDS 11 0.0006
366 ABDOMINAL PAIN UPPER 116 0.0006
367 SUBDURAL HAEMATOMA 8 0.0006
368 GASTROINTESTINAL DISORDER 50 0.0006
369 DERMATITIS ALLERGIC 7 0.0006
370 DISABILITY 11 0.0006
371 GINGIVITIS 3 0.0006
372 BEHAVIOUR DISORDER 3 0.0006
373 CHEILITIS 3 0.0006
374 OROPHARYNGEAL DISCOMFORT 5 0.0006
375 LEUKOCYTOSIS 10 0.0006
376 INTERVERTEBRAL DISC PROTRUSION 12 0.0005
377 BONE DISORDER 10 0.0005
378 MAJOR DEPRESSION 4 0.0005
379 MOUTH HAEMORRHAGE 4 0.0005
380 PHOTOSENSITIVITY REACTION 9 0.0005
381 HYPERSENSITIVITY 100 0.0005
382 FEELING DRUNK 4 0.0005
383 RESPIRATORY TRACT INFECTION 14 0.0005
384 WOUND 15 0.0005
385 PHOTOPHOBIA 10 0.0005
386 ARTERIOSCLEROSIS 5 0.0005
387 HEPATIC ENZYME INCREASED 36 0.0005
388 NASAL CONGESTION 31 0.0005
389 SCAB 6 0.0005
390 ERYTHEMA 108 0.0005
391 OSTEONECROSIS OF JAW 13 0.0005
392 MICTURITION URGENCY 6 0.0005
393 INTERNAL HAEMORRHAGE 6 0.0005
394 EYE HAEMORRHAGE 7 0.0005
395 HYPERTHERMIA 4 0.0005
396 BLOOD ALKALINE PHOSPHATASE INCREASED 13 0.0005
397 BLOOD URIC ACID INCREASED 3 0.0005
398 OSTEOARTHRITIS 22 0.0005
399 PRODUCT TASTE ABNORMAL 7 0.0005
400 ECZEMA 27 0.0005
401 VITAMIN D DEFICIENCY 5 0.0005
402 ACUTE HEPATIC FAILURE 7 0.0005
403 PHARYNGEAL SWELLING 5 0.0005
404 TORSADE DE POINTES 4 0.0005
405 DECREASED INTEREST 3 0.0005
406 GLUCOSE TOLERANCE IMPAIRED 3 0.0005
407 PNEUMOTHORAX 8 0.0005
408 COUGH 141 0.0005
409 ACCIDENT 6 0.0005
410 SWELLING 47 0.0005
411 SCIATICA 8 0.0005
412 SKIN REACTION 7 0.0005
413 EMPHYSEMA 5 0.0005
414 BURSITIS 6 0.0005
415 INGUINAL HERNIA 3 0.0005
416 ORAL PAIN 11 0.0005
417 INTENTIONAL DOSE OMISSION 14 0.0005
418 MOTOR DYSFUNCTION 5 0.0005
419 BRONCHOSPASM 7 0.0005
420 THROAT IRRITATION 22 0.0005
421 GLOMERULAR FILTRATION RATE DECREASED 6 0.0005
422 EAR DISCOMFORT 5 0.0005
423 CONCOMITANT DISEASE AGGRAVATED 3 0.0005
424 PHARYNGITIS 6 0.0005
425 INFECTION 70 0.0005
426 HYPERTHYROIDISM 7 0.0005
427 PRODUCTIVE COUGH 23 0.0005
428 SECOND PRIMARY MALIGNANCY 4 0.0005
429 EOSINOPHIL COUNT INCREASED 4 0.0005
430 TENDERNESS 5 0.0005
431 SKIN DISORDER 16 0.0005
432 HYPERTENSION 101 0.0005
433 PERICARDITIS 8 0.0005
434 UPPER GASTROINTESTINAL HAEMORRHAGE 8 0.0005
435 KNEE ARTHROPLASTY 10 0.0005
436 PROTEINURIA 9 0.0005
437 PULMONARY MASS 7 0.0005
438 IRRITABLE BOWEL SYNDROME 10 0.0005
439 HAEMOPTYSIS 13 0.0005
440 PANCYTOPENIA 26 0.0005
441 MULTI-ORGAN FAILURE 8 0.0005
442 CHOKING 9 0.0005
443 EYE PAIN 26 0.0005
444 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 24 0.0005
445 RESPIRATORY SYNCYTIAL VIRUS INFECTION 4 0.0005
446 LOCAL SWELLING 8 0.0005
447 HYPERKALAEMIA 16 0.0005
448 PHARYNGEAL OEDEMA 7 0.0005
449 HYPOKALAEMIA 21 0.0005
450 GASTROINTESTINAL PAIN 5 0.0005
451 HAEMATOCRIT DECREASED 9 0.0005
452 PRURITUS 174 0.0005
453 RED BLOOD CELL SEDIMENTATION RATE INCREASED 5 0.0005
454 HEAD DISCOMFORT 8 0.0005
455 UPPER LIMB FRACTURE 9 0.0005
456 LIP SWELLING 15 0.0004
457 SKIN EXFOLIATION 38 0.0004
458 COVID-19 79 0.0004
459 ATRIOVENTRICULAR BLOCK COMPLETE 3 0.0004
460 FACIAL PAIN 4 0.0004
461 ENCEPHALOPATHY 11 0.0004
462 URTICARIA 75 0.0004
463 MYOSITIS 4 0.0004
464 ANAL INCONTINENCE 4 0.0004
465 EYE INFECTION 5 0.0004
466 IMPAIRED GASTRIC EMPTYING 6 0.0004
467 IMPAIRED DRIVING ABILITY 5 0.0004
468 SENSORY DISTURBANCE 7 0.0004
469 ABDOMINAL PAIN LOWER 11 0.0004
470 TOOTH LOSS 9 0.0004
471 PROCEDURAL PAIN 12 0.0004
472 BLOOD POTASSIUM DECREASED 13 0.0004
473 ORAL DISCOMFORT 6 0.0004
474 DRY MOUTH 35 0.0004
475 HEPATITIS 11 0.0004
476 MASS 6 0.0004
477 DIARRHOEA 277 0.0004
478 MOUTH ULCERATION 9 0.0004
479 SPINAL PAIN 5 0.0004
480 ANAPHYLACTIC SHOCK 11 0.0004
481 DYSPNOEA EXERTIONAL 16 0.0004
482 ASTHMA 48 0.0004
483 COVID-19 PNEUMONIA 5 0.0004
484 DIVERTICULUM 3 0.0004
485 BLOOD IRON DECREASED 5 0.0004
486 BACTERAEMIA 5 0.0004
487 INTERNATIONAL NORMALISED RATIO INCREASED 12 0.0004
488 FEAR OF INJECTION 3 0.0004
489 LIMB DISCOMFORT 13 0.0004
490 RED BLOOD CELL COUNT DECREASED 12 0.0004
491 EYE INFLAMMATION 4 0.0004
492 SUPRAVENTRICULAR TACHYCARDIA 4 0.0004
493 ANAPHYLACTIC REACTION 23 0.0004
494 AFFECT LABILITY 4 0.0004
495 DRUG-INDUCED LIVER INJURY 13 0.0004
496 FAECES SOFT 3 0.0004
497 OROPHARYNGEAL PAIN 38 0.0004
498 SKIN FISSURES 8 0.0004
499 BLOOD BILIRUBIN INCREASED 11 0.0004
500 BLADDER DISORDER 4 0.0004
501 SKIN LESION 11 0.0004
502 PANCREATITIS ACUTE 9 0.0004
503 HAEMATOCHEZIA 22 0.0004
504 INJURY 28 0.0004
505 HYPOXIA 14 0.0004
506 DIVERTICULITIS 11 0.0004
507 OSTEOPENIA 6 0.0004
508 EYELID PTOSIS 4 0.0004
509 DRY THROAT 4 0.0004
510 CHILLS 46 0.0004
511 HIP ARTHROPLASTY 6 0.0004
512 SHOCK 9 0.0004
513 VIRAL INFECTION 13 0.0004
514 NEUTROPHIL COUNT INCREASED 4 0.0004
515 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 4 0.0004
516 SKIN ULCER 10 0.0004
517 POOR VENOUS ACCESS 4 0.0004
518 CATARACT 23 0.0004
519 NODULE 5 0.0004
520 SLEEP DISORDER 27 0.0004
521 RENAL IMPAIRMENT 32 0.0004
522 PULMONARY CONGESTION 5 0.0004
523 SCRATCH 4 0.0004
524 FURUNCLE 3 0.0004
525 SUDDEN DEATH 4 0.0004
526 RESPIRATORY TRACT CONGESTION 6 0.0004
527 DYSGEUSIA 28 0.0004
528 DYSSTASIA 11 0.0004
529 URINARY TRACT INFECTION 64 0.0004
530 JOINT INJURY 8 0.0004
531 BODY HEIGHT DECREASED 4 0.0004
532 JOINT RANGE OF MOTION DECREASED 5 0.0004
533 QUALITY OF LIFE DECREASED 5 0.0004
534 CHEST PAIN 69 0.0004
535 NEURALGIA 9 0.0004
536 FOOT FRACTURE 7 0.0004
537 BLOOD URINE PRESENT 7 0.0004
538 ARTHRALGIA 153 0.0004
539 PULMONARY THROMBOSIS 4 0.0004
540 ABNORMAL FAECES 3 0.0004
541 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 26 0.0004
542 HERPES ZOSTER 21 0.0004
543 WOUND INFECTION 4 0.0004
544 HYPERAESTHESIA 3 0.0004
545 POST PROCEDURAL COMPLICATION 7 0.0004
546 PYREXIA 126 0.0004
547 LACRIMATION INCREASED 11 0.0004
548 GAMMA-GLUTAMYLTRANSFERASE INCREASED 8 0.0004
549 COAGULOPATHY 6 0.0004
550 TRANSAMINASES INCREASED 8 0.0004
551 APHONIA 5 0.0004
552 OCULAR HYPERAEMIA 17 0.0004
553 NASOPHARYNGITIS 66 0.0004
554 DYSPNOEA 202 0.0004
555 THERAPEUTIC RESPONSE UNEXPECTED 16 0.0004
556 DISSEMINATED INTRAVASCULAR COAGULATION 5 0.0004
557 HYPONATRAEMIA 20 0.0004
558 HEMIPARESIS 6 0.0004
559 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 6 0.0004
560 SWELLING FACE 23 0.0004
561 PAIN IN JAW 10 0.0004
562 FACIAL PARALYSIS 3 0.0004
563 PAIN 216 0.0004
564 PERIPHERAL SWELLING 54 0.0004
565 OEDEMA 19 0.0003
566 CHOLECYSTECTOMY 4 0.0003
567 PARALYSIS 5 0.0003
568 PARAESTHESIA ORAL 5 0.0003
569 ANAEMIA 66 0.0003
570 PRODUCT USE ISSUE 65 0.0003
571 DEAFNESS 9 0.0003
572 EYELID OEDEMA 4 0.0003
573 POST PROCEDURAL HAEMORRHAGE 4 0.0003
574 BLOOD CALCIUM INCREASED 3 0.0003
575 ARTHROPATHY 19 0.0003
576 SPLENOMEGALY 4 0.0003
577 PULMONARY HYPERTENSION 7 0.0003
578 MUSCLE RIGIDITY 4 0.0003
579 POLYNEUROPATHY 4 0.0003
580 THROAT TIGHTNESS 9 0.0003
581 INFLUENZA 37 0.0003
582 PALLOR 9 0.0003
583 ANXIETY 94 0.0003
584 RESTLESS LEGS SYNDROME 6 0.0003
585 ADRENAL INSUFFICIENCY 4 0.0003
586 INFLAMMATION 17 0.0003
587 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 18 0.0003
588 LUNG DISORDER 16 0.0003
589 DYSPEPSIA 32 0.0003
590 HYPOACUSIS 14 0.0003
591 IRON DEFICIENCY ANAEMIA 3 0.0003
592 DEVICE RELATED INFECTION 5 0.0003
593 GENERALISED OEDEMA 4 0.0003
594 INCORRECT PRODUCT ADMINISTRATION DURATION 7 0.0003
595 EYE SWELLING 12 0.0003
596 CONDITION AGGRAVATED 98 0.0003
597 DRUG INTERACTION 51 0.0003
598 EPISTAXIS 24 0.0003
599 SWOLLEN TONGUE 10 0.0003
600 BLOOD SODIUM DECREASED 6 0.0003
601 DEPRESSION 72 0.0003
602 PRODUCT DOSE OMISSION ISSUE 93 0.0003
603 HEAD INJURY 10 0.0003
604 GASTRIC ULCER 6 0.0003
605 HAEMATEMESIS 8 0.0003
606 DISEASE RECURRENCE 15 0.0003
607 FLUID RETENTION 16 0.0003
608 PREMATURE DELIVERY 5 0.0003
609 INCREASED APPETITE 6 0.0003
610 HYPERSOMNIA 9 0.0003
611 OBESITY 5 0.0003
612 HYPOTHYROIDISM 10 0.0003
613 INTRAOCULAR PRESSURE INCREASED 4 0.0003
614 PULMONARY OEDEMA 14 0.0003
615 RASH PAPULAR 7 0.0003
616 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 15 0.0003
617 BRONCHITIS 23 0.0003
618 ANOREXIA 4 0.0003
619 HERNIA 6 0.0003
620 CHROMATURIA 7 0.0003
621 HIATUS HERNIA 4 0.0003
622 WEIGHT DECREASED 86 0.0003
623 BACK DISORDER 5 0.0003
624 SURGERY 18 0.0003
625 SPEECH DISORDER 16 0.0003
626 KNEE OPERATION 3 0.0003
627 TINNITUS 14 0.0003
628 SKIN DISCOLOURATION 14 0.0003
629 NAUSEA 241 0.0003
630 BEDRIDDEN 4 0.0003
631 TACHYCARDIA 27 0.0003
632 IMMUNE SYSTEM DISORDER 4 0.0003
633 DERMATITIS ATOPIC 16 0.0003
634 LIGAMENT SPRAIN 3 0.0003
635 SARS-COV-2 TEST POSITIVE 4 0.0003
636 VENTRICULAR TACHYCARDIA 5 0.0003
637 OXYGEN SATURATION DECREASED 17 0.0003
638 THERAPEUTIC RESPONSE SHORTENED 10 0.0003
639 BURNING SENSATION 21 0.0003
640 BRAIN INJURY 3 0.0003
641 FULL BLOOD COUNT DECREASED 6 0.0003
642 FEAR 8 0.0003
643 CORONARY ARTERY DISEASE 9 0.0003
644 PRODUCT ADMINISTRATION ERROR 6 0.0003
645 DISTURBANCE IN ATTENTION 16 0.0003
646 SEPSIS 33 0.0003
647 ARRHYTHMIA 14 0.0003
648 DYSKINESIA 12 0.0003
649 THROMBOCYTOPENIA 33 0.0003
650 NEUROPATHY PERIPHERAL 28 0.0003
651 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 53 0.0003
652 OFF LABEL USE 257 0.0003
653 GINGIVAL BLEEDING 4 0.0003
654 DYSARTHRIA 11 0.0003
655 OSTEOPOROSIS 12 0.0003
656 DYSPHONIA 17 0.0003
657 SYNCOPE 29 0.0003
658 DEVICE USE ERROR 10 0.0003
659 ATRIAL FIBRILLATION 28 0.0003
660 ROAD TRAFFIC ACCIDENT 12 0.0003
661 WHITE BLOOD CELL COUNT INCREASED 11 0.0003
662 WHEEZING 17 0.0003
663 FOLLICULITIS 3 0.0003
664 BLISTER 16 0.0003
665 DYSPHAGIA 27 0.0003
666 INCONTINENCE 3 0.0003
667 COLD SWEAT 5 0.0003
668 NEPHROLITHIASIS 13 0.0003
669 CONTUSION 27 0.0003
670 BACK PAIN 65 0.0003
671 NEUTROPENIA 38 0.0003
672 OEDEMA PERIPHERAL 34 0.0003
673 BLOOD CHOLESTEROL INCREASED 13 0.0003
674 DISCOMFORT 17 0.0003
675 EYE IRRITATION 16 0.0003
676 DEHYDRATION 37 0.0003
677 DEEP VEIN THROMBOSIS 18 0.0003
678 GASTROENTERITIS VIRAL 5 0.0003
679 MYELODYSPLASTIC SYNDROME 4 0.0003
680 PULMONARY ARTERIAL HYPERTENSION 4 0.0003
681 BACK INJURY 3 0.0003
682 COMPLICATION ASSOCIATED WITH DEVICE 4 0.0003
683 CHOLELITHIASIS 9 0.0003
684 HEADACHE 172 0.0003
685 IMPAIRED HEALING 9 0.0003
686 OSTEONECROSIS 9 0.0003
687 SUICIDAL IDEATION 25 0.0003
688 EMOTIONAL DISTRESS 33 0.0003
689 BLOOD PRESSURE DECREASED 18 0.0003
690 EXPOSURE VIA SKIN CONTACT 7 0.0003
691 DRUG EFFECT LESS THAN EXPECTED 4 0.0003
692 URINARY RETENTION 9 0.0003
693 CONJUNCTIVITIS 5 0.0003
694 COLON CANCER 4 0.0003
695 MIDDLE INSOMNIA 5 0.0003
696 ARTHRITIS 21 0.0003
697 THERAPY NON-RESPONDER 12 0.0003
698 FISTULA 3 0.0003
699 BLOOD CALCIUM DECREASED 3 0.0003
700 ABDOMINAL PAIN 62 0.0003
701 PRODUCT USE IN UNAPPROVED INDICATION 66 0.0003
702 CONSTIPATION 58 0.0003
703 HEART RATE IRREGULAR 6 0.0003
704 HYPOAESTHESIA ORAL 4 0.0003
705 HYPOCALCAEMIA 5 0.0003
706 PLEURAL EFFUSION 16 0.0003
707 MUSCULOSKELETAL DISORDER 5 0.0003
708 INTENTIONAL PRODUCT USE ISSUE 23 0.0003
709 MUSCULOSKELETAL STIFFNESS 23 0.0003
710 HEART RATE INCREASED 26 0.0003
711 DRY SKIN 35 0.0003
712 MIGRAINE 25 0.0003
713 PULMONARY FIBROSIS 5 0.0003
714 JAUNDICE 7 0.0003
715 ABDOMINAL DISTENSION 27 0.0003
716 MUSCULOSKELETAL CHEST PAIN 4 0.0003
717 ANKLE FRACTURE 4 0.0003
718 HAEMORRHAGE 27 0.0003
719 CAESAREAN SECTION 3 0.0003
720 RENAL DISORDER 12 0.0003
721 DELUSION 4 0.0003
722 VOMITING 121 0.0003
723 THERAPY PARTIAL RESPONDER 4 0.0003
724 NERVOUS SYSTEM DISORDER 8 0.0003
725 TREATMENT NONCOMPLIANCE 14 0.0003
726 ASTHENIA 96 0.0003
727 KIDNEY INFECTION 5 0.0003
728 RESPIRATORY DISTRESS 7 0.0003
729 ACTIVITIES OF DAILY LIVING IMPAIRED 5 0.0003
730 FEELING COLD 7 0.0003
731 NECK PAIN 14 0.0003
732 PNEUMONIA 81 0.0002
733 WEIGHT INCREASED 56 0.0002
734 WHITE BLOOD CELL COUNT DECREASED 27 0.0002
735 MALAISE 109 0.0002
736 PAIN IN EXTREMITY 73 0.0002
737 MENTAL IMPAIRMENT 6 0.0002
738 HYPOAESTHESIA 37 0.0002
739 PANIC ATTACK 9 0.0002
740 BONE MARROW FAILURE 5 0.0002
741 DEPRESSED MOOD 13 0.0002
742 DYSURIA 9 0.0002
743 ANGINA PECTORIS 7 0.0002
744 CHEST DISCOMFORT 25 0.0002
745 METASTASES TO BONE 4 0.0002
746 PRODUCT PREPARATION ERROR 5 0.0002
747 BALANCE DISORDER 21 0.0002
748 LOWER RESPIRATORY TRACT INFECTION 11 0.0002
749 DRUG LEVEL INCREASED 4 0.0002
750 AGEUSIA 6 0.0002
751 DRY EYE 12 0.0002
752 LEUKOPENIA 12 0.0002
753 BLOOD UREA INCREASED 4 0.0002
754 FACE OEDEMA 4 0.0002
755 RENAL FAILURE ACUTE 10 0.0002
756 HYPOPHAGIA 6 0.0002
757 RETCHING 5 0.0002
758 FALL 78 0.0002
759 HAEMATURIA 8 0.0002
760 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 4 0.0002
761 IRRITABILITY 14 0.0002
762 POOR QUALITY SLEEP 5 0.0002
763 SKIN CANCER 5 0.0002
764 HEPATIC FAILURE 7 0.0002
765 APHASIA 7 0.0002
766 HAEMATOMA 6 0.0002
767 PULMONARY EMBOLISM 22 0.0002
768 INJECTION SITE INDURATION 3 0.0002
769 DEVICE DEFECTIVE 4 0.0002
770 FAECES DISCOLOURED 5 0.0002
771 AMNESIA 15 0.0002
772 MULTIPLE SCLEROSIS 11 0.0002
773 HYPOTENSION 46 0.0002
774 HAND DEFORMITY 3 0.0002
775 ALANINE AMINOTRANSFERASE INCREASED 14 0.0002
776 BLOOD TRIGLYCERIDES INCREASED 4 0.0002
777 LYMPHOCYTE COUNT DECREASED 4 0.0002
778 BRADYCARDIA 12 0.0002
779 MATERNAL EXPOSURE DURING PREGNANCY 20 0.0002
780 HAEMOGLOBIN DECREASED 23 0.0002
781 THERAPY INTERRUPTED 16 0.0002
782 THIRST 4 0.0002
783 MUSCLE SPASMS 41 0.0002
784 MOBILITY DECREASED 16 0.0002
785 FREQUENT BOWEL MOVEMENTS 6 0.0002
786 PALPITATIONS 26 0.0002
787 COMPLICATION OF DEVICE REMOVAL 4 0.0002
788 CYSTITIS 7 0.0002
789 PRODUCT AVAILABILITY ISSUE 5 0.0002
790 DEVICE MECHANICAL ISSUE 3 0.0002
791 LOSS OF CONSCIOUSNESS 28 0.0002
792 CENTRAL NERVOUS SYSTEM LESION 3 0.0002
793 PERICARDIAL EFFUSION 5 0.0002
794 GENERAL PHYSICAL HEALTH DETERIORATION 25 0.0002
795 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 5 0.0002
796 EYE DISORDER 7 0.0002
797 DIZZINESS 106 0.0002
798 INTESTINAL OBSTRUCTION 8 0.0002
799 PRODUCT DOSE OMISSION IN ERROR 6 0.0002
800 THROMBOSIS 17 0.0002
801 INFUSION RELATED REACTION 14 0.0002
802 EXPIRED PRODUCT ADMINISTERED 7 0.0002
803 INSOMNIA 56 0.0002
804 PARAESTHESIA 33 0.0002
805 GAIT INABILITY 7 0.0002
806 FATIGUE 163 0.0002
807 SEIZURE 24 0.0002
808 GLAUCOMA 4 0.0002
809 ERUCTATION 4 0.0002
810 CARDIAC ARREST 17 0.0002
811 RESPIRATORY FAILURE 15 0.0002
812 FIBROMYALGIA 5 0.0002
813 BLOOD PRESSURE SYSTOLIC INCREASED 4 0.0002
814 ANGIOEDEMA 9 0.0002
815 DISORIENTATION 8 0.0002
816 BLOOD PRESSURE ABNORMAL 4 0.0002
817 RHINORRHOEA 13 0.0002
818 ABORTION SPONTANEOUS 8 0.0002
819 BONE LOSS 3 0.0002
820 HEART RATE DECREASED 7 0.0002
821 UNEVALUABLE EVENT 15 0.0002
822 INTENTIONAL SELF-INJURY 4 0.0002
823 THERAPEUTIC RESPONSE DECREASED 12 0.0002
824 SUICIDE ATTEMPT 12 0.0002
825 ACNE 15 0.0002
826 DEVICE FAILURE 3 0.0002
827 VERTIGO 12 0.0002
828 FLATULENCE 11 0.0002
829 C-REACTIVE PROTEIN INCREASED 7 0.0002
830 FEELING ABNORMAL 46 0.0002
831 POLLAKIURIA 8 0.0002
832 BONE DENSITY DECREASED 6 0.0002
833 BLOOD LACTATE DEHYDROGENASE INCREASED 3 0.0002
834 SOMNOLENCE 38 0.0002
835 ASPARTATE AMINOTRANSFERASE INCREASED 10 0.0002
836 BONE PAIN 11 0.0002
837 PLATELET COUNT DECREASED 20 0.0002
838 LIVER FUNCTION TEST INCREASED 4 0.0002
839 RECTAL HAEMORRHAGE 8 0.0002
840 PAIN OF SKIN 5 0.0002
841 BLOOD POTASSIUM INCREASED 3 0.0002
842 BLOOD CREATININE INCREASED 12 0.0002
843 PSORIASIS 24 0.0002
844 PNEUMONITIS 5 0.0002
845 BLOOD PRESSURE INCREASED 28 0.0002
846 INFLUENZA LIKE ILLNESS 15 0.0002
847 MELAENA 4 0.0002
848 CYTOMEGALOVIRUS INFECTION 3 0.0002
849 HEPATOTOXICITY 4 0.0002
850 GLOSSODYNIA 4 0.0002
851 HYPERHIDROSIS 23 0.0002
852 SNEEZING 4 0.0002
853 TYPE 2 DIABETES MELLITUS 6 0.0002
854 TRANSIENT ISCHAEMIC ATTACK 6 0.0002
855 MUSCULAR WEAKNESS 20 0.0002
856 HOSPITALISATION 27 0.0002
857 SKIN IRRITATION 8 0.0002
858 JOINT SWELLING 21 0.0002
859 LETHARGY 10 0.0002
860 BLOOD CREATINE PHOSPHOKINASE INCREASED 5 0.0002
861 MUSCLE TWITCHING 4 0.0002
862 HOT FLUSH 13 0.0002
863 GAIT DISTURBANCE 33 0.0002
864 MUSCULOSKELETAL PAIN 9 0.0002
865 NEEDLE ISSUE 5 0.0002
866 ACUTE RESPIRATORY DISTRESS SYNDROME 3 0.0002
867 SYSTEMIC LUPUS ERYTHEMATOSUS 6 0.0002
868 URINARY INCONTINENCE 5 0.0002
869 TREMOR 28 0.0002
870 ISCHAEMIC STROKE 3 0.0002
871 MEMORY IMPAIRMENT 23 0.0002
872 GOUT 3 0.0002
873 MYELOSUPPRESSION 6 0.0002
874 HYPOGLYCAEMIA 8 0.0002
875 PRESYNCOPE 4 0.0002
876 RESTLESSNESS 6 0.0002
877 INJECTION SITE RASH 5 0.0002
878 INJECTION SITE BRUISING 13 0.0002
879 EMOTIONAL DISORDER 5 0.0002
880 CARDIAC DISORDER 15 0.0002
881 CARDIOVASCULAR DISORDER 4 0.0002
882 MOOD SWINGS 5 0.0002
883 INJECTION SITE SWELLING 12 0.0002
884 DEVICE ISSUE 14 0.0002
885 ERECTILE DYSFUNCTION 4 0.0002
886 MOVEMENT DISORDER 5 0.0002
887 NIGHT SWEATS 5 0.0002
888 RASH GENERALISED 4 0.0002
889 PLASMA CELL MYELOMA 6 0.0002
890 MUCOSAL INFLAMMATION 4 0.0002
891 SEDATION 4 0.0002
892 ABNORMAL BEHAVIOUR 6 0.0002
893 PANCREATITIS 8 0.0002
894 FEBRILE NEUTROPENIA 10 0.0002
895 DECREASED APPETITE 35 0.0002
896 INJECTION SITE PRURITUS 10 0.0001
897 EYE PRURITUS 5 0.0001
898 CONFUSIONAL STATE 24 0.0001
899 DEVICE BREAKAGE 6 0.0001
900 FEELING HOT 9 0.0001
901 DRUG INEFFECTIVE 193 0.0001
902 NIGHTMARE 5 0.0001
903 DELIRIUM 5 0.0001
904 MENTAL STATUS CHANGES 4 0.0001
905 INJECTION SITE PAIN 44 0.0001
906 HALLUCINATION, VISUAL 3 0.0001
907 IMPAIRED WORK ABILITY 3 0.0001
908 ALTERED STATE OF CONSCIOUSNESS 3 0.0001
909 HYPERGLYCAEMIA 5 0.0001
910 VISUAL IMPAIRMENT 17 0.0001
911 INTENTIONAL PRODUCT MISUSE 12 0.0001
912 INJECTION SITE MASS 5 0.0001
913 PREMATURE BABY 4 0.0001
914 HALLUCINATION 10 0.0001
915 RHEUMATOID ARTHRITIS 15 0.0001
916 GASTROINTESTINAL HAEMORRHAGE 11 0.0001
917 INCORRECT DOSE ADMINISTERED 30 0.0001
918 DIABETES MELLITUS 10 0.0001
919 GYNAECOMASTIA 4 0.0001
920 DISEASE PROGRESSION 15 0.0001
921 MEDICATION ERROR 7 0.0001
922 DIABETIC KETOACIDOSIS 3 0.0001
923 PSORIATIC ARTHROPATHY 5 0.0001
924 ADVERSE DRUG REACTION 11 0.0001
925 TREATMENT FAILURE 10 0.0001
926 RHABDOMYOLYSIS 5 0.0001
927 CARDIO-RESPIRATORY ARREST 5 0.0001
928 DRUG EXPOSURE DURING PREGNANCY 4 0.0001
929 VISION BLURRED 16 0.0001
930 ACCIDENTAL EXPOSURE TO PRODUCT 12 0.0001
931 INJECTION SITE REACTION 8 0.0001
932 DIPLOPIA 3 0.0001
933 STOMATITIS 7 0.0001
934 DEVICE DISLOCATION 5 0.0001
935 MENTAL DISORDER 5 0.0001
936 CEREBROVASCULAR ACCIDENT 19 0.0001
937 COLITIS ULCERATIVE 5 0.0001
938 MYALGIA 19 0.0001
939 CEREBRAL HAEMORRHAGE 4 0.0001
940 ABNORMAL DREAMS 3 0.0001
941 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 22 0.0001
942 PRODUCT DOSE OMISSION 7 0.0001
943 ASCITES 3 0.0001
944 LABORATORY TEST ABNORMAL 3 0.0001
945 ILL-DEFINED DISORDER 6 0.0001
946 BLINDNESS 4 0.0001
947 NEUTROPHIL COUNT DECREASED 4 0.0001
948 SKIN BURNING SENSATION 7 0.0001
949 MYOCARDIAL INFARCTION 17 0.0001
950 ALOPECIA 19 0.0001
951 UNDERDOSE 7 0.0001
952 NERVOUSNESS 5 0.0001
953 HIP FRACTURE 3 0.0001
954 VAGINAL HAEMORRHAGE 4 0.0001
955 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 3 0.0001
956 ANGER 3 0.0001
957 INJECTION SITE ERYTHEMA 11 0.0001
958 CONVULSION 5 0.0001
959 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 4 0.0001
960 ELECTROCARDIOGRAM QT PROLONGED 3 0.0001
961 BLOOD GLUCOSE DECREASED 4 0.0001
962 INTERSTITIAL LUNG DISEASE 4 0.0001
963 CRYING 3 0.0001
964 ACCIDENTAL OVERDOSE 3 0.0001
965 AGITATION 6 0.0001
966 EXPOSURE DURING PREGNANCY 5 0.0001
967 HEPATIC FUNCTION ABNORMAL 3 0.0001
968 FLUSHING 8 0.0001
969 MALIGNANT NEOPLASM PROGRESSION 8 0.0001
970 THERAPY CESSATION 4 0.0001
971 NEOPLASM MALIGNANT 5 0.0001
972 OVERDOSE 16 0.0001
973 MULTIPLE SCLEROSIS RELAPSE 5 0.0001
974 DEVICE LEAKAGE 3 0.0001
975 COGNITIVE DISORDER 3 0.0001
976 DEVICE DIFFICULT TO USE 4 0.0001
977 BLOOD GLUCOSE INCREASED 11 0.0001
978 PRODUCT STORAGE ERROR 5 0.0001
979 ADVERSE EVENT 5 0.0001
980 DEATH 46 0.0001
981 PRODUCT QUALITY ISSUE 7 0.0001
982 DRUG DOSE OMISSION BY DEVICE 4 0.0001
983 NO ADVERSE EVENT 9 0.0000
984 BREAST CANCER 4 0.0000
985 DRUG DEPENDENCE 6 0.0000
986 DRUG ABUSE 3 0.0000
987 DRUG WITHDRAWAL SYNDROME 3 0.0000
988 TOXICITY TO VARIOUS AGENTS 5 0.0000
989 DRUG DOSE OMISSION 3 0.0000